Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Exenatide bij Parkinson: geen voordeel op langere termijn
mrt 2025 | Bewegingsstoornissen